These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 1289890
1. [The validation of the adequacy of chemotherapy in bladder tuberculosis based on a study of bacteriostatic activity]. Dovlatian AA, Dzhenzhera NA. Probl Tuberk; 1992; (11-12):49-51. PubMed ID: 1289890 [Abstract] [Full Text] [Related]
2. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels. Agrawal S, Singh I, Kaur KJ, Bhade SR, Kaul CL, Panchagnula R. Int J Pharm; 2004 May 19; 276(1-2):41-9. PubMed ID: 15113612 [Abstract] [Full Text] [Related]
3. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis. Garg SK, Dhand R, Malik SK, Kalra S, Gupta PH, Jha VK, Shukla VK, Lal R. Int J Clin Pharmacol Ther Toxicol; 1988 Aug 19; 26(8):417-20. PubMed ID: 3220617 [Abstract] [Full Text] [Related]
4. [Drug therapy of urogenital tuberculosis]. König K. Urologe; 1970 Jan 19; 9(1):44. PubMed ID: 5461516 [No Abstract] [Full Text] [Related]
5. [Blood bacteriostatic activity in patients with tuberculosis of the urogenital system undergoing different methods of administration of antibacterial drugs]. Gabinskiĭ BSh. Probl Tuberk; 1971 Jan 19; 49(2):80-2. PubMed ID: 5105489 [No Abstract] [Full Text] [Related]
6. [Urogenital tuberculosis. Apropos of 40 cases]. el Khader K, el Fassi J, Karmouni T, Tazi K, Ibnattya A, Hachimi M, Lakrissa A. Ann Urol (Paris); 1997 Jan 19; 31(6-7):339-43. PubMed ID: 9509233 [Abstract] [Full Text] [Related]
7. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule. Zwolska Z, Augustynowicz-Kopeć E, Niemirowska-Mikulska H. Acta Pol Pharm; 2002 Jan 19; 59(6):448-52. PubMed ID: 12669769 [Abstract] [Full Text] [Related]
8. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R. Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281 [Abstract] [Full Text] [Related]
14. [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide]. Schaberg T, Lode H. Z Gesamte Inn Med; 1991 Jun 11; 46(8):276-9. PubMed ID: 1897286 [Abstract] [Full Text] [Related]
18. Rationale and experimental data in support of the use of a fixed-triple combination of isoniazid, rifampicin and pyrazinamide in the chemotherapy of tuberculosis. Acocella G. G Ital Chemioter; 1987 Jun 11; 34(1-3):3-5. PubMed ID: 3504412 [No Abstract] [Full Text] [Related]
19. [Rifampicin in the treatment of urogenital tuberculosis. Apropos of the 1st 100 cases in man treated in a sanatorium]. Kalachnikoff P, Lengrand J, Herreros V. Ann Urol (Paris); 1972 May 11; 6(2):113-8. PubMed ID: 5053197 [No Abstract] [Full Text] [Related]
20. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats. De Rosa HJ, Baldan HM, Brunetti IL, Ximenes VF, Machado RG. Biopharm Drug Dispos; 2007 Sep 11; 28(6):291-6. PubMed ID: 17571294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]